SCHEMBL8285142

SCHEMBL8285142

O=c1cc(Nc2ccccc2)n(-c2ccccc2)c2nc(NCc3ccccc3)cc(C(F)(F)F)c12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.60
CYP1A2 P05177 2/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2D6 P10635 2/20 0.37
TSHR P16473 2/20 0.37
CYP2C19 P33261 2/20 0.37
HIF1A Q16665 1/20 0.37
CYP2C9 P11712 1/20 0.37
HSD17B10 Q99714 1/20 0.37
MAT2A P31153 1/20 0.37
KDM4E B2RXH2 3/20 0.36
ADORA3 P0DMS8 2/20 0.36
ADORA2A P29274 1/20 0.36
ADORA2B P29275 1/20 0.36
ADORA1 P30542 1/20 0.36
PTGS2 P35354 2/20 0.36
SLC2A1 P11166 1/20 0.36
PTK2 Q05397 1/20 0.36
FABP4 P15090 1/20 0.36
AR P10275 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287850 0.94 PDE11A (0.56) PDE11AADORA2APTGS2PTK2LMNA
SCHEMBL8286369 0.87 PDE11A (0.59) PDE11ATSHRKDM4ELMNAGAA
SCHEMBL8287114 0.87 PDE11A (0.59) PDE11ACYP1A2CYP2C19CYP2C9HSD17B10
SCHEMBL8287908 0.86 PDE11A (0.45) PDE11AMAT2AKDM4EADORA3ADORA2A
SCHEMBL8287838 0.86 PDE11A (0.57) PDE11ACYP1A2TSHRCYP2C19CYP2C9
SCHEMBL8287507 0.85 PDE11A (0.59) PDE11ACYP1A2TSHRHSD17B10MAT2A
SCHEMBL8287857 0.85 PDE11A (0.56) PDE11ACYP1A2CYP3A4TSHRCYP2C19
SCHEMBL8285152 0.85 PDE11A (0.56) PDE11ALMNAMAPTMEN1KMT2A
SCHEMBL8285156 0.84 PDE11A (0.56) PDE11ACYP1A2MAT2AKDM4EPTK2
SCHEMBL8285267 0.84 PDE11A (0.62) PDE11ACYP1A2PTK2LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed